BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12546333)

  • 1. Montelukast reduces peripheral blood eosinophilia but not tissue eosinophilia or symptoms in a patient with eosinophilic gastroenteritis and esophageal stricture.
    Daikh BE; Ryan CK; Schwartz RH
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):23-7. PubMed ID: 12546333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic gastroenteritis in a young girl--long term remission under Montelukast.
    Quack I; Sellin L; Buchner NJ; Theegarten D; Rump LC; Henning BF
    BMC Gastroenterol; 2005 Jul; 5():24. PubMed ID: 16026609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma.
    Jayaram L; Duong M; Pizzichini MM; Pizzichini E; Kamada D; Efthimiadis A; Hargreave FE
    Eur Respir J; 2005 Jan; 25(1):41-6. PubMed ID: 15640321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic cystitis: successful long-term treatment with montelukast sodium.
    Sterrett S; Morton J; Perry D; Donovan J
    Urology; 2006 Feb; 67(2):423.e19-423.e21. PubMed ID: 16461108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast as a treatment modality for eosinophilic gastroenteritis.
    De Maeyer N; Kochuyt AM; Van Moerkercke W; Hiele M
    Acta Gastroenterol Belg; 2011 Dec; 74(4):570-5. PubMed ID: 22319970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis.
    Razi C; Bakirtas A; Harmanci K; Turktas I; Erbas D
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):767-74. PubMed ID: 17201236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis.
    Schwartz DA; Pardi DS; Murray JA
    Dig Dis Sci; 2001 Aug; 46(8):1787-90. PubMed ID: 11508684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
    Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM
    Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
    Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
    Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of treatment with montelukast on in vitro interleukin-10 production of mononuclear cells of children with asthma.
    Stelmach I; Majak P; Jerzynska J; Kuna P
    Clin Exp Allergy; 2005 Feb; 35(2):213-20. PubMed ID: 15725194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of montelukast on eosinophilic gastroenteritis in a mouse model.
    Wan D; Liu X; Li G
    Immunopharmacol Immunotoxicol; 2013 Apr; 35(2):292-5. PubMed ID: 23240855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.
    Ramsay CF; Sullivan P; Gizycki M; Wang D; Swern AS; Barnes NC; Reiss TF; Jeffery PK
    Respir Med; 2009 Jul; 103(7):995-1003. PubMed ID: 19249198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of eosinophilic gastroenteritis with montelukast.
    Neustrom MR; Friesen C
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):506. PubMed ID: 10452782
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-inflammatory effects of montelukast in mild cystic fibrosis.
    Schmitt-Grohé S; Eickmeier O; Schubert R; Bez C; Zielen S
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):599-605. PubMed ID: 12487226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malabsorption syndrome and leukotriene inhibitor.
    Selva Kumar C; Das RR; Balakrishnan CD; Balagurunathan K; Chaudhuri K
    J Trop Pediatr; 2011 Apr; 57(2):135-7. PubMed ID: 20571153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.
    Patel P; Philip G; Yang W; Call R; Horak F; LaForce C; Gilles L; Garrett GC; Dass SB; Knorr BA; Reiss TF
    Ann Allergy Asthma Immunol; 2005 Dec; 95(6):551-7. PubMed ID: 16400895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic gastroenteritis: a challenge to diagnose and treat.
    Phaw NA; Tsai HH
    BMJ Case Rep; 2016 Sep; 2016():. PubMed ID: 27613263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
    van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children.
    Gagro A; Aberle N; Rabatić S; Ajduk J; Jelacić J; Dekaris D
    Clin Exp Allergy; 2004 Jun; 34(6):939-44. PubMed ID: 15196283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast: use in pediatric patients with eosinophilic gastrointestinal disease.
    Vanderhoof JA; Young RJ; Hanner TL; Kettlehut B
    J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):293-4. PubMed ID: 12548071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.